| Financial Year |
March 31 2023 |
| Monetary Funds |
876,151,882.25 |
| Held-for-trading Financial Assets |
330,000,000.00 |
| Notes Receivable |
12,836,842.49 |
| Accounts Receivable |
1,084,270,825.01 |
| Advances to Suppliers |
33,772,397.82 |
| Other Receivables |
14,923,288.59 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
246,347,816.88 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
2,776,786.47 |
| Other Current Assets |
4,029,738.75 |
| Total Current Assets |
2,645,030,799.32 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
19,306,737.24 |
| Investment Properties |
191,312,800.40 |
| Fixed Assetes |
19,299,695.15 |
| Under-construction Projects |
51,242,190.20 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
33,426,037.53 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
3,666,063.75 |
| Deferred Income Tax Assets |
46,468,673.89 |
| Other Non-Current Assets |
32,965,028.40 |
| Sub-Total of Non-Current Assets |
545,417,374.20 |
| Total Assets |
3,190,448,173.52 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
212,507,713.94 |
| Accounts Payable |
281,554,805.66 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
18,586,712.03 |
| Taxes Payable |
115,673,154.52 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
74,457,581.70 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
13,103,341.06 |
| Other Current Liabilities |
4,000,000.00 |
| Sub-Total of Current Liabilities |
946,416,689.35 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
42,788,487.09 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
70,033,096.56 |
| Total Liabilities |
1,016,449,785.91 |
| Paid-In Capital(Or Share Stock) |
258,041,750.00 |
| Capital Surplus |
1,049,566,188.72 |
| Surplus Reserve |
97,875,590.38 |
| LESS:Treasury Stock |
61,706,223.87 |
| Undistributed Profits |
830,038,138.58 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,173,998,387.61 |
| Owner's Equity（Stockholder's Equity） |
2,173,998,387.61 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,190,448,173.52 |
